Header Logo

Alan Go

Concepts (944)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Renal Insufficiency, Chronic
115
2026
189
19.910
Why?
Atrial Fibrillation
111
2026
173
18.140
Why?
Heart Failure
79
2026
403
13.030
Why?
Stroke
95
2026
297
12.500
Why?
Kidney Failure, Chronic
52
2025
144
8.820
Why?
Aged
318
2026
5901
8.030
Why?
Humans
498
2026
16832
7.750
Why?
Anticoagulants
67
2024
127
7.700
Why?
Acute Kidney Injury
31
2026
45
7.560
Why?
Cardiovascular Diseases
59
2026
520
7.230
Why?
Myocardial Infarction
55
2026
215
7.230
Why?
Male
350
2026
9556
7.100
Why?
Female
363
2026
12193
6.670
Why?
Middle Aged
283
2026
7515
6.470
Why?
Risk Factors
191
2026
3108
6.040
Why?
Warfarin
39
2023
72
5.610
Why?
Hospitalization
56
2026
816
5.490
Why?
Glomerular Filtration Rate
68
2026
157
5.430
Why?
Aged, 80 and over
117
2026
1887
5.400
Why?
Risk Assessment
76
2026
1047
5.010
Why?
Coronary Artery Disease
28
2022
79
4.830
Why?
Coronary Disease
22
2019
125
3.880
Why?
Retrospective Studies
93
2026
2463
3.790
Why?
Cohort Studies
107
2026
2396
3.780
Why?
Adult
147
2026
7255
3.590
Why?
California
79
2026
2244
3.570
Why?
Coronary Artery Bypass
11
2016
25
3.510
Why?
Venous Thromboembolism
10
2023
55
3.480
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
16
2026
155
3.460
Why?
Kidney
17
2026
51
3.410
Why?
United States
134
2026
3858
3.230
Why?
Incidence
72
2026
1229
3.200
Why?
Heart Diseases
24
2019
71
3.180
Why?
Registries
41
2022
449
3.170
Why?
Disease Progression
42
2026
252
3.100
Why?
Treatment Outcome
60
2025
1098
3.090
Why?
Ventricular Function, Left
20
2026
54
2.980
Why?
American Heart Association
23
2025
49
2.940
Why?
Hypertension
19
2025
475
2.850
Why?
Percutaneous Coronary Intervention
10
2016
23
2.830
Why?
Stroke Volume
20
2026
110
2.770
Why?
Prospective Studies
84
2026
1186
2.620
Why?
Atherosclerosis
13
2026
51
2.600
Why?
Follow-Up Studies
67
2026
1058
2.410
Why?
Time Factors
52
2024
989
2.380
Why?
Prognosis
55
2026
568
2.330
Why?
Adrenergic beta-Antagonists
13
2025
42
2.320
Why?
Renal Dialysis
19
2025
57
2.310
Why?
Angiotensin-Converting Enzyme Inhibitors
8
2022
80
2.190
Why?
Creatinine
22
2026
67
2.180
Why?
Proteinuria
12
2025
24
2.170
Why?
Thromboembolism
15
2023
32
2.150
Why?
Delivery of Health Care, Integrated
12
2026
515
2.060
Why?
Biomarkers
43
2026
284
1.940
Why?
Natural Language Processing
4
2025
60
1.910
Why?
Angiotensin Receptor Antagonists
4
2022
51
1.870
Why?
Emergency Service, Hospital
12
2025
393
1.810
Why?
Hemorrhage
26
2023
62
1.760
Why?
Primary Prevention
9
2018
60
1.750
Why?
Kidney Diseases
11
2011
51
1.750
Why?
Heart Failure, Systolic
3
2025
5
1.710
Why?
Cause of Death
22
2026
171
1.700
Why?
Patient Discharge
11
2024
152
1.690
Why?
Defibrillators, Implantable
8
2018
29
1.660
Why?
Proportional Hazards Models
39
2021
657
1.650
Why?
Biomedical Research
9
2024
73
1.630
Why?
Severity of Illness Index
25
2026
410
1.610
Why?
Intracranial Hemorrhages
8
2026
16
1.570
Why?
Continental Population Groups
13
2021
255
1.550
Why?
Blood Pressure
19
2025
278
1.510
Why?
Patient Readmission
9
2020
161
1.500
Why?
Platelet Aggregation Inhibitors
9
2021
24
1.480
Why?
Comorbidity
32
2023
516
1.460
Why?
Age Factors
36
2026
814
1.440
Why?
Cardiology
8
2025
28
1.440
Why?
Death, Sudden, Cardiac
8
2018
27
1.440
Why?
Brain Ischemia
13
2016
36
1.410
Why?
Anti-Arrhythmia Agents
5
2025
11
1.390
Why?
Hyperkalemia
2
2022
14
1.370
Why?
Ventricular Dysfunction, Left
8
2017
18
1.290
Why?
Research Report
7
2020
23
1.250
Why?
Renin-Angiotensin System
2
2020
16
1.250
Why?
Mortality
13
2021
116
1.250
Why?
Predictive Value of Tests
26
2026
325
1.230
Why?
Aortic Valve Stenosis
3
2026
7
1.230
Why?
Cystatin C
8
2026
14
1.220
Why?
Pulmonary Embolism
4
2020
46
1.190
Why?
Polymorphism, Single Nucleotide
18
2015
305
1.160
Why?
National Heart, Lung, and Blood Institute (U.S.)
8
2023
19
1.160
Why?
Outpatients
4
2023
99
1.150
Why?
Prevalence
36
2018
785
1.100
Why?
Anemia
8
2020
34
1.090
Why?
Diabetes Mellitus
11
2019
445
1.080
Why?
Young Adult
38
2026
2456
1.070
Why?
Medication Adherence
4
2026
235
1.070
Why?
Survival Rate
25
2026
247
1.050
Why?
Morbidity
5
2020
56
1.040
Why?
Atrial Flutter
7
2023
16
1.030
Why?
Practice Guidelines as Topic
9
2026
311
1.030
Why?
International Normalized Ratio
14
2022
21
1.010
Why?
Fibrinolytic Agents
14
2016
45
1.010
Why?
Catheter Ablation
4
2019
11
1.000
Why?
Digoxin
4
2025
12
0.990
Why?
Cross-Sectional Studies
41
2022
1233
0.980
Why?
Electric Countershock
7
2017
13
0.980
Why?
Machine Learning
3
2026
60
0.970
Why?
Multivariate Analysis
23
2019
489
0.960
Why?
Troponin I
3
2016
8
0.960
Why?
Algorithms
8
2021
210
0.930
Why?
Odds Ratio
20
2016
569
0.900
Why?
Influenza Vaccines
2
2025
300
0.890
Why?
Vitamin K
10
2022
14
0.890
Why?
Angioplasty, Balloon, Coronary
3
2014
9
0.890
Why?
Multiple Chronic Conditions
2
2023
22
0.880
Why?
Influenza, Human
2
2025
292
0.880
Why?
Genome-Wide Association Study
10
2026
209
0.880
Why?
Venous Thrombosis
3
2020
23
0.870
Why?
Chronic Disease
14
2023
382
0.870
Why?
Outcome Assessment (Health Care)
9
2018
199
0.850
Why?
Hispanic Americans
12
2016
350
0.850
Why?
Heart Rate
7
2025
33
0.850
Why?
Cardiomyopathies
3
2015
8
0.840
Why?
Potassium
2
2022
14
0.830
Why?
Cognition Disorders
6
2017
30
0.830
Why?
Vaccination
3
2025
725
0.820
Why?
Drug-Eluting Stents
4
2014
7
0.810
Why?
Disease Management
6
2020
106
0.810
Why?
Adolescent
26
2026
3464
0.810
Why?
Ticlopidine
9
2016
16
0.800
Why?
Peripheral Arterial Disease
6
2021
13
0.800
Why?
Neoplasms
8
2026
447
0.800
Why?
European Continental Ancestry Group
16
2017
400
0.800
Why?
Secondary Prevention
3
2020
44
0.790
Why?
Dabigatran
6
2018
8
0.770
Why?
Hemoglobins
6
2020
38
0.760
Why?
Clinical Trials as Topic
10
2016
114
0.760
Why?
Echocardiography
8
2026
22
0.760
Why?
Transcatheter Aortic Valve Replacement
1
2022
2
0.760
Why?
African Americans
12
2022
394
0.750
Why?
Office Visits
2
2020
78
0.730
Why?
Quality of Life
15
2024
477
0.730
Why?
Pregnancy Complications, Cardiovascular
2
2013
23
0.720
Why?
Forecasting
2
2021
67
0.720
Why?
Survival Analysis
12
2019
191
0.720
Why?
Telephone
2
2020
157
0.710
Why?
Fibroblast Growth Factors
6
2019
12
0.700
Why?
Glomerulosclerosis, Focal Segmental
1
2021
1
0.700
Why?
Glomerulonephritis, Membranous
1
2021
1
0.700
Why?
Nephrotic Syndrome
1
2021
2
0.700
Why?
Chi-Square Distribution
14
2015
129
0.700
Why?
Propensity Score
7
2019
78
0.690
Why?
Myocardial Revascularization
6
2026
12
0.690
Why?
Sex Factors
18
2024
560
0.690
Why?
Hypertrophy, Left Ventricular
9
2017
11
0.690
Why?
Troponin T
9
2025
11
0.690
Why?
Medicare
8
2022
188
0.680
Why?
Education
2
2020
14
0.670
Why?
Aftercare
2
2020
46
0.670
Why?
Dementia
2
2023
137
0.670
Why?
Eicosapentaenoic Acid
1
2021
9
0.660
Why?
Arrhythmias, Cardiac
2
2018
23
0.660
Why?
Kaplan-Meier Estimate
11
2019
110
0.660
Why?
Drug Monitoring
2
2020
23
0.650
Why?
Case-Control Studies
20
2016
995
0.650
Why?
Logistic Models
20
2016
796
0.650
Why?
Mobility Limitation
1
2020
15
0.650
Why?
Electronic Health Records
7
2026
702
0.640
Why?
Electrocardiography
15
2024
30
0.640
Why?
Independent Living
1
2020
24
0.640
Why?
Angina Pectoris
4
2007
6
0.640
Why?
Aspirin
11
2016
61
0.630
Why?
Longitudinal Studies
15
2021
653
0.630
Why?
Dopamine Agonists
1
2020
2
0.630
Why?
Inpatients
3
2017
78
0.630
Why?
Hyperprolactinemia
1
2020
3
0.620
Why?
Data Accuracy
1
2020
26
0.620
Why?
Practice Patterns, Physicians'
7
2017
290
0.620
Why?
Heart Valve Diseases
1
2020
14
0.620
Why?
Aging
4
2019
146
0.620
Why?
Databases, Factual
7
2019
294
0.620
Why?
Renal Insufficiency
2
2023
10
0.600
Why?
Inflammation
5
2024
56
0.600
Why?
Research Design
8
2012
319
0.590
Why?
Coronavirus Infections
1
2020
49
0.590
Why?
Pneumonia, Viral
1
2020
56
0.590
Why?
Cholesterol, LDL
6
2026
113
0.580
Why?
Genetic Predisposition to Disease
11
2026
319
0.580
Why?
Lung Diseases
2
2017
34
0.580
Why?
Cardiovascular Agents
3
2020
21
0.580
Why?
Pandemics
2
2022
289
0.570
Why?
Guideline Adherence
5
2026
155
0.560
Why?
Antithrombins
2
2017
4
0.560
Why?
Patient Selection
11
2014
175
0.560
Why?
Kidney Transplantation
4
2014
28
0.550
Why?
Body Mass Index
9
2015
925
0.550
Why?
Sex Characteristics
4
2015
58
0.540
Why?
Quality Indicators, Health Care
3
2017
126
0.540
Why?
Patient Acceptance of Health Care
2
2021
353
0.540
Why?
Obesity
6
2015
811
0.530
Why?
Postoperative Hemorrhage
2
2015
8
0.520
Why?
Metabolic Syndrome
6
2026
59
0.520
Why?
Kidney Function Tests
8
2022
21
0.520
Why?
Peptide Fragments
7
2025
29
0.520
Why?
Non-ST Elevated Myocardial Infarction
2
2016
8
0.520
Why?
Natriuretic Peptide, Brain
7
2025
28
0.520
Why?
Albuminuria
5
2025
39
0.520
Why?
Population Surveillance
5
2013
242
0.510
Why?
Image Interpretation, Computer-Assisted
3
2026
12
0.500
Why?
Age Distribution
11
2019
221
0.500
Why?
Cardiotonic Agents
2
2013
12
0.490
Why?
Electrocardiography, Ambulatory
2
2016
2
0.490
Why?
Diabetic Cardiomyopathies
1
2016
4
0.490
Why?
Surveys and Questionnaires
12
2020
1204
0.490
Why?
ST Elevation Myocardial Infarction
1
2016
7
0.480
Why?
Factor Xa Inhibitors
4
2020
10
0.480
Why?
Data Collection
7
2020
223
0.480
Why?
African Continental Ancestry Group
7
2021
117
0.480
Why?
Health Maintenance Organizations
11
2017
358
0.480
Why?
Bradycardia
1
2016
1
0.470
Why?
Sinus Arrest, Cardiac
1
2016
1
0.470
Why?
Atrioventricular Block
1
2016
1
0.470
Why?
Tachycardia, Ventricular
1
2016
4
0.470
Why?
Overweight
3
2010
262
0.470
Why?
Evidence-Based Medicine
6
2016
160
0.460
Why?
Calcinosis
7
2012
18
0.450
Why?
Randomized Controlled Trials as Topic
9
2026
317
0.440
Why?
Clinical Laboratory Techniques
1
2015
12
0.440
Why?
Primary Health Care
1
2020
693
0.440
Why?
Aortic Valve
2
2026
6
0.430
Why?
Diphosphonates
3
2011
63
0.430
Why?
Stents
1
2014
5
0.430
Why?
Delivery of Health Care
3
2020
374
0.430
Why?
Vascular Calcification
3
2022
8
0.430
Why?
Heart Function Tests
1
2014
3
0.420
Why?
Administration, Oral
13
2022
81
0.410
Why?
Ontario
2
2026
20
0.400
Why?
Blood Pressure Determination
7
2025
57
0.400
Why?
Hypertension, Pregnancy-Induced
2
2025
40
0.400
Why?
Spironolactone
1
2013
7
0.400
Why?
Ethnic Groups
7
2021
418
0.390
Why?
Birth Rate
1
2013
3
0.390
Why?
Coronary Vessels
5
2022
7
0.390
Why?
Heart Valve Prosthesis Implantation
3
2026
5
0.390
Why?
Recovery of Function
4
2020
25
0.380
Why?
Multimorbidity
2
2023
11
0.380
Why?
Child, Preschool
8
2021
1430
0.380
Why?
Sex Distribution
10
2019
164
0.380
Why?
Likelihood Functions
1
2012
45
0.370
Why?
Quality Improvement
2
2013
184
0.370
Why?
Monitoring, Ambulatory
1
2012
17
0.370
Why?
Asian Americans
5
2011
146
0.370
Why?
Interleukin-6
4
2022
24
0.360
Why?
Diabetic Retinopathy
3
2020
17
0.360
Why?
Infant
5
2023
1212
0.360
Why?
Motor Activity
6
2013
196
0.360
Why?
Acute Disease
5
2019
144
0.360
Why?
Sensitivity and Specificity
12
2015
291
0.360
Why?
Angina, Stable
1
2011
2
0.350
Why?
Reproducibility of Results
15
2026
346
0.350
Why?
Recurrence
4
2020
149
0.350
Why?
Heart Ventricles
4
2017
7
0.350
Why?
Puerperal Disorders
1
2011
7
0.350
Why?
Coronary Restenosis
1
2011
1
0.340
Why?
Antihypertensive Agents
4
2016
157
0.340
Why?
Mouth Diseases
1
2011
3
0.340
Why?
Outcome and Process Assessment (Health Care)
6
2017
85
0.340
Why?
Oral Health
1
2011
17
0.330
Why?
Drug Therapy, Combination
7
2019
104
0.330
Why?
Heart
3
2023
8
0.330
Why?
Risk
11
2016
453
0.330
Why?
Quality of Health Care
6
2013
249
0.330
Why?
Community Health Services
2
2008
68
0.330
Why?
Vascular Diseases
1
2010
5
0.330
Why?
Erythropoietin
3
2007
3
0.330
Why?
Patient Compliance
3
2020
262
0.330
Why?
Asian Continental Ancestry Group
4
2012
69
0.320
Why?
Child
8
2021
2433
0.320
Why?
Blood Coagulation Factors
3
2022
5
0.320
Why?
Osteoporosis
1
2011
73
0.320
Why?
Cognition
2
2024
90
0.310
Why?
Graft Rejection
1
2009
3
0.310
Why?
Mental Disorders
4
2015
248
0.310
Why?
Health Literacy
2
2022
39
0.300
Why?
Genotype
10
2026
198
0.300
Why?
Confidence Intervals
7
2014
207
0.300
Why?
Nocturia
1
2009
1
0.290
Why?
Uric Acid
1
2009
6
0.290
Why?
Artificial Intelligence
2
2026
26
0.290
Why?
Data Interpretation, Statistical
5
2016
67
0.290
Why?
Diuretics
2
2022
17
0.280
Why?
Information Services
1
2008
7
0.280
Why?
Hospital Mortality
6
2009
134
0.280
Why?
Communicable Diseases
1
2008
14
0.280
Why?
Decision Support Techniques
4
2020
87
0.270
Why?
Text Messaging
2
2026
39
0.270
Why?
Oligosaccharides
1
2008
2
0.270
Why?
C-Reactive Protein
5
2017
52
0.270
Why?
Decision Support Systems, Clinical
3
2024
55
0.270
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
2
0.270
Why?
Sepsis
2
2023
64
0.260
Why?
Carbazoles
1
2007
2
0.260
Why?
Tartrates
1
2007
2
0.260
Why?
Propanolamines
1
2007
3
0.260
Why?
Metoprolol
1
2007
6
0.260
Why?
Atenolol
1
2007
6
0.260
Why?
Bundle-Branch Block
4
2000
5
0.260
Why?
Adiposity
2
2015
69
0.260
Why?
Anti-Asthmatic Agents
3
2007
85
0.260
Why?
Vascular Surgical Procedures
3
2015
5
0.260
Why?
Hematinics
1
2007
3
0.250
Why?
Cardiac Resynchronization Therapy
3
2017
4
0.250
Why?
Membrane Proteins
2
2022
29
0.250
Why?
Renal Replacement Therapy
2
2023
8
0.250
Why?
Measles virus
1
2026
1
0.250
Why?
Abdomen
1
2006
19
0.250
Why?
High-Throughput Nucleotide Sequencing
1
2026
5
0.250
Why?
Whole Genome Sequencing
1
2026
11
0.250
Why?
Echocardiography, Doppler
1
2026
3
0.250
Why?
Cardio-Renal Syndrome
1
2026
3
0.250
Why?
Genome, Viral
1
2026
8
0.250
Why?
Heart Conduction System
2
2018
3
0.240
Why?
Pre-Eclampsia
2
2025
41
0.240
Why?
Product Surveillance, Postmarketing
2
2025
99
0.240
Why?
Measles
1
2026
25
0.240
Why?
Growth Differentiation Factor 15
3
2022
4
0.240
Why?
Vascular Stiffness
2
2017
4
0.230
Why?
Diabetes Mellitus, Type 2
4
2024
677
0.230
Why?
Dyslipidemias
3
2015
57
0.230
Why?
Transcriptome
1
2026
19
0.230
Why?
Thrombophilia
2
2015
3
0.230
Why?
Polycystic Ovary Syndrome
1
2006
18
0.230
Why?
Quantitative Trait Loci
3
2015
29
0.230
Why?
Wearable Electronic Devices
1
2025
6
0.230
Why?
Process Assessment (Health Care)
2
2017
22
0.230
Why?
Antineoplastic Agents
1
2026
58
0.230
Why?
Life Style
3
2022
305
0.230
Why?
Coronary Angiography
3
2014
16
0.230
Why?
Hawaii
1
2025
62
0.230
Why?
Hypolipidemic Agents
2
2020
38
0.230
Why?
Lower Extremity
2
2015
18
0.230
Why?
Health Behavior
4
2016
332
0.230
Why?
Comparative Effectiveness Research
3
2015
60
0.220
Why?
Embolism
3
2015
6
0.220
Why?
Telemedicine
2
2020
190
0.220
Why?
Thrombolytic Therapy
4
2001
19
0.220
Why?
Systole
5
2016
21
0.220
Why?
Research
4
2017
53
0.220
Why?
Health Status Indicators
4
2020
58
0.220
Why?
Poverty
2
2024
167
0.220
Why?
Insulin
4
2015
181
0.210
Why?
Blood Glucose
4
2016
315
0.210
Why?
Cerebral Hemorrhage
3
2014
11
0.210
Why?
Asthma
3
2007
375
0.210
Why?
Patient Care Management
1
2004
22
0.210
Why?
Echocardiography, Transesophageal
1
2004
3
0.210
Why?
Analysis of Variance
5
2017
120
0.210
Why?
Postoperative Complications
3
2016
103
0.210
Why?
Lung
2
2018
52
0.200
Why?
Specialization
3
2001
18
0.200
Why?
Medicine
3
2001
15
0.200
Why?
Health Knowledge, Attitudes, Practice
3
2017
352
0.200
Why?
Cholesterol, HDL
4
2023
64
0.200
Why?
Interleukin-1 Receptor-Like 1 Protein
2
2022
3
0.200
Why?
Pregnancy
4
2025
1555
0.200
Why?
Genetic Variation
3
2014
67
0.200
Why?
Thiophenes
2
2013
2
0.200
Why?
Factor Xa
2
2013
2
0.200
Why?
Morpholines
2
2013
3
0.200
Why?
Acute Coronary Syndrome
2
2016
18
0.190
Why?
Protective Factors
2
2020
28
0.190
Why?
Models, Statistical
4
2012
164
0.190
Why?
Thrombosis
1
2023
16
0.190
Why?
Academies and Institutes
1
2023
4
0.190
Why?
Factor V
1
2003
4
0.190
Why?
Aortic Aneurysm, Thoracic
1
2022
1
0.190
Why?
Serine Endopeptidases
1
2022
4
0.190
Why?
Prosthesis Implantation
3
2015
8
0.190
Why?
Triglycerides
2
2021
78
0.190
Why?
Factor IX
1
2022
2
0.190
Why?
Lipocalin-2
3
2017
3
0.190
Why?
Terminology as Topic
3
2010
14
0.190
Why?
Meals
1
2022
7
0.190
Why?
Lipids
3
2019
66
0.180
Why?
Health Status
5
2018
256
0.180
Why?
Retinal Vessels
2
2020
5
0.180
Why?
Observational Studies as Topic
2
2020
44
0.180
Why?
Emergency Medical Services
2
2021
41
0.180
Why?
Dietary Approaches To Stop Hypertension
1
2022
8
0.180
Why?
Sodium Chloride Symporter Inhibitors
1
2022
9
0.180
Why?
Nephrosis, Lipoid
1
2021
1
0.180
Why?
Risk Reduction Behavior
2
2020
97
0.180
Why?
Churg-Strauss Syndrome
3
2007
6
0.170
Why?
Mentoring
1
2022
29
0.170
Why?
Angioedema
1
2021
5
0.170
Why?
Antiviral Agents
1
2022
92
0.170
Why?
Health Services Accessibility
2
2020
262
0.170
Why?
Animals
5
2021
237
0.170
Why?
Biopsy
1
2021
74
0.170
Why?
Calcium
3
2012
27
0.170
Why?
Fibrinogen
3
2017
11
0.170
Why?
Chitinase-3-Like Protein 1
1
2021
1
0.170
Why?
Chemokine CCL2
1
2021
1
0.170
Why?
Kidney Tubules
1
2021
1
0.170
Why?
Asymptomatic Diseases
3
2016
23
0.170
Why?
Intention to Treat Analysis
1
2021
19
0.170
Why?
Chromosomes, Human, Pair 9
2
2013
4
0.170
Why?
Angina, Unstable
4
2014
7
0.170
Why?
HIV Infections
2
2022
708
0.160
Why?
Leukotriene Antagonists
2
2007
12
0.160
Why?
Jaw Diseases
2
2011
8
0.160
Why?
Osteonecrosis
2
2011
9
0.160
Why?
Clinical Decision-Making
1
2020
33
0.160
Why?
Appointments and Schedules
1
2020
25
0.160
Why?
Hip Fractures
2
2016
72
0.160
Why?
Patient Reported Outcome Measures
1
2020
48
0.160
Why?
Respiratory Tract Infections
1
2021
58
0.160
Why?
Hepatitis A Virus Cellular Receptor 1
2
2017
2
0.160
Why?
Fatty Acid-Binding Proteins
2
2017
2
0.160
Why?
Arginine
2
2010
9
0.160
Why?
Physicians
1
2021
114
0.160
Why?
Cognitive Dysfunction
2
2024
61
0.160
Why?
Europe
4
2015
40
0.160
Why?
Long Term Adverse Effects
1
2020
5
0.160
Why?
Cigarette Smoking
1
2020
4
0.160
Why?
Anemia, Iron-Deficiency
1
2020
6
0.160
Why?
Diabetic Nephropathies
3
2010
24
0.160
Why?
Vasodilation
2
2011
3
0.150
Why?
Pyrazoles
1
2019
3
0.150
Why?
Pyridines
2
2016
8
0.150
Why?
Executive Function
2
2017
29
0.150
Why?
Population Dynamics
1
2019
7
0.150
Why?
Ischemic Attack, Transient
3
2014
21
0.150
Why?
Pyridones
1
2019
9
0.150
Why?
Attitude to Health
1
2020
142
0.150
Why?
Gastrointestinal Diseases
2
2018
26
0.150
Why?
Dose-Response Relationship, Drug
3
2017
110
0.150
Why?
Cost-Benefit Analysis
3
2016
229
0.150
Why?
Health Care Costs
4
2014
192
0.150
Why?
International Classification of Diseases
2
2020
84
0.150
Why?
Patient Participation
1
2020
120
0.150
Why?
Healthcare Disparities
3
2017
213
0.140
Why?
Smoking Cessation
1
2020
140
0.140
Why?
Reoperation
2
2016
24
0.140
Why?
Withholding Treatment
3
2020
26
0.140
Why?
Disease-Free Survival
3
2019
54
0.140
Why?
Genetic Loci
2
2015
41
0.140
Why?
Validation Studies as Topic
1
2017
11
0.130
Why?
Drug Administration Schedule
3
2019
94
0.130
Why?
Advisory Committees
2
2009
112
0.130
Why?
Estrogen Replacement Therapy
3
2003
91
0.130
Why?
Cardiologists
1
2017
4
0.130
Why?
Patient Admission
1
2018
58
0.130
Why?
Lipoprotein(a)
1
2017
5
0.130
Why?
Acclimatization
1
2017
1
0.130
Why?
Cyclooxygenase Inhibitors
1
2017
2
0.130
Why?
Hypoglycemic Agents
2
2012
247
0.130
Why?
Ventilation
1
2017
2
0.130
Why?
Hypoxia
1
2017
7
0.130
Why?
Ibuprofen
1
2017
8
0.130
Why?
beta-Alanine
3
2013
3
0.130
Why?
Cardiac Pacing, Artificial
1
2017
1
0.130
Why?
Pacemaker, Artificial
1
2017
2
0.130
Why?
Benzimidazoles
3
2013
5
0.130
Why?
Tomography, X-Ray Computed
5
2012
203
0.130
Why?
Epigenesis, Genetic
2
2015
25
0.130
Why?
Mice
3
2021
59
0.130
Why?
Ankle Brachial Index
2
2021
6
0.130
Why?
Acetylglucosaminidase
1
2017
1
0.130
Why?
Awareness
1
2017
17
0.130
Why?
Health Policy
2
2016
101
0.130
Why?
Urine Specimen Collection
1
2016
1
0.120
Why?
Urine
1
2016
5
0.120
Why?
Prosthesis Failure
1
2016
2
0.120
Why?
Fee-for-Service Plans
2
2014
20
0.120
Why?
Thiazoles
1
2016
10
0.120
Why?
Prosthesis Design
1
2016
6
0.120
Why?
Drug Labeling
1
2016
12
0.120
Why?
Crotalid Venoms
1
2016
1
0.120
Why?
Atrial Appendage
1
2016
1
0.120
Why?
Computer Simulation
2
2016
84
0.120
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
167
0.120
Why?
Kidney Neoplasms
2
2014
15
0.120
Why?
Up-Regulation
1
2016
5
0.120
Why?
Health Information Systems
1
2016
3
0.120
Why?
Cytokines
1
2016
28
0.120
Why?
Patient Education as Topic
2
2017
186
0.120
Why?
Hyponatremia
1
2016
6
0.120
Why?
Heart Block
1
2016
1
0.120
Why?
Data Mining
1
2016
18
0.120
Why?
Thrombophlebitis
1
2016
2
0.120
Why?
Heart Defects, Congenital
1
2016
17
0.120
Why?
Anesthesia, Conduction
1
1996
1
0.120
Why?
Sick Sinus Syndrome
1
2015
1
0.120
Why?
Anesthesia, General
1
1996
2
0.120
Why?
Hypoalbuminemia
1
2015
1
0.120
Why?
Blood Coagulation Tests
1
2015
1
0.120
Why?
Drug Prescriptions
1
2016
137
0.120
Why?
Socioeconomic Factors
5
2019
571
0.120
Why?
Cord Blood Stem Cell Transplantation
1
2015
1
0.120
Why?
Intermittent Claudication
1
2015
1
0.120
Why?
Hematologic Neoplasms
1
2015
8
0.120
Why?
Ischemia
1
2015
4
0.110
Why?
Community Networks
2
2014
19
0.110
Why?
Endovascular Procedures
1
2015
6
0.110
Why?
Recombinant Proteins
4
2011
16
0.110
Why?
Hypertriglyceridemia
1
2015
12
0.110
Why?
Body Size
1
2015
27
0.110
Why?
Incidental Findings
3
2013
25
0.110
Why?
Phosphates
1
2015
5
0.110
Why?
Brachial Artery
2
2014
3
0.110
Why?
Chemokine CX3CL1
1
2015
1
0.110
Why?
Biological Assay
1
2015
1
0.110
Why?
Healthy Volunteers
1
2015
2
0.110
Why?
Body Fat Distribution
1
2015
4
0.110
Why?
Peer Group
1
2015
50
0.110
Why?
United States Food and Drug Administration
3
2025
33
0.110
Why?
Multicenter Studies as Topic
2
2008
76
0.110
Why?
Retreatment
1
2014
2
0.110
Why?
Quality-Adjusted Life Years
4
2019
41
0.110
Why?
Acute-Phase Proteins
1
2014
2
0.110
Why?
Lipocalins
1
2014
2
0.110
Why?
Adipose Tissue
1
2015
63
0.110
Why?
Epidemiologic Research Design
1
2014
18
0.110
Why?
Ventricular Remodeling
3
2023
6
0.110
Why?
Proto-Oncogene Proteins
1
2014
31
0.110
Why?
Gastrointestinal Hemorrhage
1
2014
21
0.110
Why?
Body Height
1
2014
54
0.110
Why?
Echocardiography, Stress
1
2014
2
0.110
Why?
Cardiac Catheterization
1
2014
4
0.110
Why?
Poisson Distribution
3
2012
84
0.100
Why?
Computer Communication Networks
1
2014
9
0.100
Why?
Myocardial Perfusion Imaging
1
2014
2
0.100
Why?
Regression Analysis
5
2016
261
0.100
Why?
Serotonin Uptake Inhibitors
1
2014
45
0.100
Why?
Chemokine CXCL12
1
2013
3
0.100
Why?
Creatine
1
2013
4
0.100
Why?
Voluntary Health Agencies
1
2013
1
0.100
Why?
Social Class
3
2023
106
0.100
Why?
Centers for Disease Control and Prevention (U.S.)
1
2013
32
0.100
Why?
Gait
1
2013
8
0.100
Why?
Health Priorities
1
2013
21
0.100
Why?
DNA Methylation
1
2014
44
0.100
Why?
Gene Frequency
3
2008
26
0.100
Why?
Hospitalists
1
2013
8
0.100
Why?
Proteomics
2
2023
10
0.100
Why?
Postural Balance
1
2013
12
0.100
Why?
Patient Outcome Assessment
1
2013
26
0.100
Why?
Statistics as Topic
4
2012
54
0.100
Why?
Medicare Part C
1
2013
11
0.100
Why?
Models, Theoretical
1
2013
66
0.100
Why?
Cost of Illness
2
2005
90
0.100
Why?
Age of Onset
3
2008
66
0.100
Why?
Disease Models, Animal
3
2021
17
0.100
Why?
Digestive System Diseases
1
2013
3
0.100
Why?
Insulin Resistance
2
2015
127
0.100
Why?
Chemoprevention
1
2012
11
0.100
Why?
Retinal Diseases
1
2012
6
0.090
Why?
Chest Pain
4
2000
15
0.090
Why?
Hypertensive Retinopathy
1
2012
3
0.090
Why?
Mass Screening
2
2024
670
0.090
Why?
Personnel Selection
1
2012
3
0.090
Why?
Marketing of Health Services
1
2012
4
0.090
Why?
Transforming Growth Factor beta
3
2017
8
0.090
Why?
Tumor Necrosis Factor-alpha
3
2017
24
0.090
Why?
Ambulatory Care
3
2014
205
0.090
Why?
Anti-Bacterial Agents
2
2004
145
0.090
Why?
Nitroglycerin
2
2011
2
0.090
Why?
Magnetic Resonance Angiography
2
2011
3
0.090
Why?
Vasodilator Agents
2
2011
4
0.090
Why?
Medicare Part D
1
2012
17
0.090
Why?
Patient-Centered Care
1
2014
185
0.090
Why?
Community-Based Participatory Research
1
2012
45
0.090
Why?
Adamantane
1
2012
3
0.090
Why?
Dipeptides
1
2012
3
0.090
Why?
Mice, Knockout
2
2011
10
0.090
Why?
Cooperative Behavior
2
2009
84
0.090
Why?
Central Nervous System Stimulants
1
2011
23
0.090
Why?
Societies, Medical
1
2012
67
0.090
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2011
1
0.090
Why?
Coronary Circulation
1
2011
1
0.090
Why?
Blood Flow Velocity
2
2009
4
0.090
Why?
Pulse
2
2009
4
0.090
Why?
Tibial Arteries
1
2011
3
0.080
Why?
Infant, Newborn, Diseases
1
2011
34
0.080
Why?
Dental Care
1
2011
15
0.080
Why?
Models, Biological
3
2016
26
0.080
Why?
Tryptophan
1
2010
1
0.080
Why?
Kinesin
1
2010
1
0.080
Why?
Attention Deficit Disorder with Hyperactivity
1
2011
64
0.080
Why?
Health Promotion
1
2013
277
0.080
Why?
Time
1
2010
16
0.080
Why?
Postmenopause
2
2001
243
0.080
Why?
Markov Chains
3
2016
19
0.080
Why?
Psychiatric Status Rating Scales
1
2010
100
0.080
Why?
Interviews as Topic
1
2011
305
0.080
Why?
Calcium Channel Blockers
2
2025
13
0.080
Why?
Pharmacogenetics
2
2008
13
0.080
Why?
Magnetic Resonance Imaging
1
2010
107
0.080
Why?
Intensive Care Units
2
2009
102
0.080
Why?
Vascular Resistance
1
2009
1
0.080
Why?
Aorta
1
2009
2
0.080
Why?
Blood Coagulation
1
2009
3
0.080
Why?
Transplantation, Homologous
1
2009
3
0.080
Why?
Confounding Factors (Epidemiology)
3
2012
77
0.080
Why?
Nephrectomy
1
2009
6
0.080
Why?
Research Support as Topic
1
2009
15
0.080
Why?
Depression
1
2014
479
0.080
Why?
Activities of Daily Living
2
2008
71
0.080
Why?
Dialysis
1
2009
1
0.080
Why?
Anticholesteremic Agents
1
2009
12
0.070
Why?
Evaluation Studies as Topic
1
2009
27
0.070
Why?
Gemfibrozil
1
2009
5
0.070
Why?
Rivaroxaban
2
2023
8
0.070
Why?
Carcinoma, Basal Cell
1
2009
23
0.070
Why?
Glycated Hemoglobin A
4
2016
176
0.070
Why?
Linear Models
3
2017
187
0.070
Why?
Bone Density Conservation Agents
1
2009
55
0.070
Why?
Cluster Analysis
2
2024
88
0.070
Why?
Infant, Newborn
1
2011
828
0.070
Why?
Diabetes Complications
3
2010
93
0.070
Why?
Health Services Research
2
2017
180
0.070
Why?
Health Surveys
3
2017
226
0.070
Why?
Needs Assessment
2
2016
64
0.070
Why?
Communicable Disease Control
1
2008
19
0.070
Why?
Mental Health
1
2010
161
0.070
Why?
Risk Adjustment
1
2008
17
0.070
Why?
Scavenger Receptors, Class E
1
2008
1
0.070
Why?
Arachidonate 5-Lipoxygenase
1
2008
2
0.070
Why?
Carrier Proteins
1
2008
11
0.070
Why?
Colorado
3
2015
171
0.070
Why?
Program Development
1
2008
62
0.070
Why?
Antifibrinolytic Agents
2
2005
3
0.070
Why?
Endpoint Determination
3
2012
10
0.070
Why?
Myocardial Ischemia
2
2013
21
0.070
Why?
Platelet Membrane Glycoproteins
1
2007
1
0.070
Why?
Matrix Metalloproteinase 2
1
2007
1
0.070
Why?
Matrix Metalloproteinase 9
1
2007
2
0.070
Why?
Matrix Metalloproteinases
1
2007
3
0.070
Why?
Fibrin Fibrinogen Degradation Products
1
2007
6
0.070
Why?
Arachidonate 12-Lipoxygenase
1
2007
2
0.070
Why?
Arachidonate 15-Lipoxygenase
1
2007
2
0.070
Why?
Glycemic Index
1
2007
17
0.070
Why?
Arteries
1
2007
7
0.070
Why?
Chemokines
1
2007
5
0.070
Why?
Multiphasic Screening
1
2007
5
0.060
Why?
Anti-HIV Agents
1
2009
163
0.060
Why?
Molecular Epidemiology
2
2008
33
0.060
Why?
Aluminum
1
2007
15
0.060
Why?
Aortic Aneurysm, Abdominal
1
2007
6
0.060
Why?
Epoetin Alfa
1
2007
1
0.060
Why?
Medical Records
4
2016
85
0.060
Why?
Photography
2
2020
11
0.060
Why?
Urinalysis
2
2017
9
0.060
Why?
Abdominal Fat
1
2006
10
0.060
Why?
Leptin
1
2006
24
0.060
Why?
Interleukin 1 Receptor Antagonist Protein
2
2017
10
0.060
Why?
Memory
2
2017
13
0.060
Why?
Drug Utilization
2
2004
112
0.060
Why?
Review Literature as Topic
1
2026
15
0.060
Why?
Video Recording
1
2026
18
0.060
Why?
Cardiotoxicity
1
2026
4
0.060
Why?
Patient Portals
1
2026
25
0.060
Why?
Electronic Mail
1
2026
52
0.060
Why?
Gene Expression Profiling
1
2026
27
0.060
Why?
Equipment Design
2
2017
8
0.060
Why?
Cardiac Surgical Procedures
1
2005
5
0.060
Why?
Managed Care Programs
2
2004
275
0.060
Why?
Neuropsychological Tests
2
2017
47
0.060
Why?
Databases as Topic
4
2009
19
0.060
Why?
Oceanic Ancestry Group
1
2005
30
0.060
Why?
Inflammation Mediators
1
2005
6
0.060
Why?
Placenta Growth Factor
1
2025
1
0.060
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2025
1
0.060
Why?
Angiopoietin-2
1
2025
2
0.060
Why?
Vascular Endothelial Growth Factor A
1
2025
3
0.060
Why?
Waist-Hip Ratio
2
2015
17
0.060
Why?
Communication
1
2026
183
0.060
Why?
Adipogenesis
2
2015
4
0.060
Why?
Global Health
2
2016
26
0.060
Why?
Medical Record Linkage
2
2016
35
0.060
Why?
Hypothyroidism
1
2005
6
0.060
Why?
Diagnosis, Computer-Assisted
2
2015
5
0.050
Why?
Rats
2
2017
33
0.050
Why?
Macrolides
1
2004
4
0.050
Why?
Drug Interactions
2
2017
17
0.050
Why?
Area Under Curve
2
2019
33
0.050
Why?
ROC Curve
2
2019
68
0.050
Why?
Breast Diseases
1
2004
11
0.050
Why?
Language
2
2016
51
0.050
Why?
Enzyme-Linked Immunosorbent Assay
2
2017
10
0.050
Why?
Breast
1
2004
66
0.050
Why?
Calcitonin
1
2003
1
0.050
Why?
Osteoporosis, Postmenopausal
1
2003
42
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2022
3
0.050
Why?
Fractures, Bone
1
2003
92
0.050
Why?
Albumins
1
2022
5
0.050
Why?
RNA
1
2022
12
0.050
Why?
Models, Cardiovascular
2
2013
4
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2023
63
0.050
Why?
Social Determinants of Health
1
2023
39
0.050
Why?
Deoxycholic Acid
1
2022
1
0.050
Why?
Sample Size
2
2012
27
0.040
Why?
CD4 Lymphocyte Count
1
2022
182
0.040
Why?
Nutritive Value
1
2022
11
0.040
Why?
Observer Variation
3
2010
34
0.040
Why?
Attitude
1
2022
27
0.040
Why?
Brain
1
2022
47
0.040
Why?
Feasibility Studies
2
2012
108
0.040
Why?
Patient Freedom of Choice Laws
1
2001
1
0.040
Why?
Pharmacoepidemiology
1
2001
15
0.040
Why?
Energy Metabolism
2
2015
47
0.040
Why?
Pilot Projects
2
2012
210
0.040
Why?
Smoking
3
2010
373
0.040
Why?
Cresols
1
2021
1
0.040
Why?
Glycine
1
2021
1
0.040
Why?
Indican
1
2021
1
0.040
Why?
Kynurenic Acid
1
2021
1
0.040
Why?
Pyridoxic Acid
1
2021
1
0.040
Why?
Ribonucleosides
1
2021
1
0.040
Why?
Sulfuric Acid Esters
1
2021
1
0.040
Why?
Organic Anion Transporters
1
2021
1
0.040
Why?
Xanthines
1
2021
5
0.040
Why?
Chromatography, Liquid
1
2021
6
0.040
Why?
Tandem Mass Spectrometry
1
2021
6
0.040
Why?
Health Services Misuse
1
2001
11
0.040
Why?
Health Services for the Aged
1
2001
14
0.040
Why?
Africa
2
2011
3
0.040
Why?
Heart Valves
1
2000
2
0.040
Why?
Galectins
1
2020
1
0.040
Why?
Blood Proteins
1
2020
4
0.040
Why?
Transferrins
1
2020
3
0.040
Why?
Transferrin
1
2020
4
0.040
Why?
Ferritins
1
2020
7
0.040
Why?
Contraindications
1
1999
13
0.040
Why?
Referral and Consultation
1
2001
147
0.040
Why?
Internal Medicine
1
2000
22
0.040
Why?
Family Practice
1
2000
40
0.040
Why?
Hematologic Tests
1
2019
3
0.040
Why?
Heart Arrest
1
2019
27
0.040
Why?
Datasets as Topic
1
2019
17
0.040
Why?
Diet
1
2022
349
0.040
Why?
Cardiology Service, Hospital
1
1999
1
0.040
Why?
Death
1
2019
10
0.040
Why?
Diagnosis-Related Groups
1
1999
18
0.040
Why?
Reference Values
2
2011
78
0.040
Why?
Asia
2
2011
11
0.040
Why?
Residence Characteristics
1
2020
244
0.030
Why?
Respiratory Center
1
2017
1
0.030
Why?
Solitary Nucleus
1
2017
1
0.030
Why?
Neuroglia
1
2017
2
0.030
Why?
Calcium-Binding Proteins
1
2017
2
0.030
Why?
Glial Fibrillary Acidic Protein
1
2017
2
0.030
Why?
Microfilament Proteins
1
2017
3
0.030
Why?
Rats, Sprague-Dawley
1
2017
9
0.030
Why?
Cardiac Resynchronization Therapy Devices
1
2017
2
0.030
Why?
Drug Substitution
1
2017
9
0.030
Why?
Interleukin-1beta
1
2017
2
0.030
Why?
Pulse Wave Analysis
1
2017
3
0.030
Why?
Comprehension
1
2017
19
0.030
Why?
Hypercholesterolemia
2
2010
24
0.030
Why?
Interleukin-18
1
2016
1
0.030
Why?
Organ Size
1
2016
16
0.030
Why?
Diastole
1
2016
5
0.030
Why?
Myocardial Reperfusion
2
2007
2
0.030
Why?
Heparin, Low-Molecular-Weight
2
2008
10
0.030
Why?
Iothalamic Acid
1
2016
2
0.030
Why?
Interleukin-1
1
2016
2
0.030
Why?
Serum Albumin
1
2016
4
0.030
Why?
Septal Occluder Device
1
2016
1
0.030
Why?
Accidental Falls
1
2016
49
0.030
Why?
Decision Trees
1
2016
16
0.030
Why?
Data Curation
1
2016
1
0.030
Why?
Goals
1
2016
27
0.030
Why?
Sweden
1
2016
17
0.030
Why?
Orientation
1
2016
1
0.030
Why?
Trail Making Test
1
2016
1
0.030
Why?
Psychomotor Performance
1
2016
4
0.030
Why?
Monte Carlo Method
1
2016
10
0.030
Why?
Intraoperative Complications
1
1996
4
0.030
Why?
Attention
1
2016
11
0.030
Why?
Medical Informatics
1
2016
34
0.030
Why?
Cuba
1
2015
1
0.030
Why?
Dominican Republic
1
2015
1
0.030
Why?
South America
1
2015
2
0.030
Why?
Central America
1
2015
2
0.030
Why?
Puerto Rico
1
2015
5
0.030
Why?
Cell Line
2
2012
9
0.030
Why?
Diagnosis
1
1995
3
0.030
Why?
Allografts
1
2015
1
0.030
Why?
Chromosome Mapping
1
2015
15
0.030
Why?
Caregivers
1
2017
132
0.030
Why?
Mexico
1
2015
16
0.030
Why?
Platelet Count
1
2015
10
0.030
Why?
Surgical Wound Infection
1
2015
4
0.030
Why?
Leukocyte Count
1
2015
23
0.030
Why?
Amputation
1
2015
11
0.030
Why?
Diabetic Angiopathies
1
2015
33
0.030
Why?
Nutrition Surveys
1
2015
56
0.030
Why?
Myocardial Contraction
1
2015
1
0.030
Why?
Retinal Artery
1
2015
2
0.030
Why?
Retinal Vein
1
2015
2
0.030
Why?
Angiography
1
2015
9
0.030
Why?
Frail Elderly
1
2015
9
0.030
Why?
Glutamic Acid
1
2015
3
0.030
Why?
Neovascularization, Physiologic
1
2015
2
0.030
Why?
Adipocytes
1
2015
4
0.030
Why?
Transcription, Genetic
1
2015
6
0.030
Why?
Synapses
1
2015
2
0.030
Why?
Genome, Human
1
2015
24
0.030
Why?
Stress Disorders, Post-Traumatic
1
2015
70
0.030
Why?
Psychotic Disorders
1
2015
52
0.030
Why?
Peripheral Vascular Diseases
1
2014
2
0.030
Why?
Clinical Competence
1
1995
107
0.030
Why?
Anxiety Disorders
1
2015
96
0.030
Why?
Genetics, Population
1
2014
8
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2014
18
0.030
Why?
Radial Artery
1
2014
2
0.030
Why?
Femoral Artery
1
2014
3
0.030
Why?
San Francisco
2
2008
54
0.030
Why?
Epithelial-Mesenchymal Transition
1
2014
1
0.030
Why?
Metabolic Clearance Rate
1
2013
4
0.030
Why?
Information Dissemination
1
2014
43
0.030
Why?
Depressive Disorder
1
2015
177
0.030
Why?
Muscle Weakness
1
2013
3
0.030
Why?
Drug Synergism
1
2013
2
0.020
Why?
Capitation Fee
1
2013
6
0.020
Why?
Fatigue
1
2013
30
0.020
Why?
Reimbursement, Incentive
1
2013
19
0.020
Why?
Geography
1
2013
39
0.020
Why?
Cerebrovascular Disorders
1
2013
29
0.020
Why?
Peritoneal Dialysis
1
2013
6
0.020
Why?
History, Ancient
1
2013
2
0.020
Why?
Ultrasonography
1
2013
32
0.020
Why?
Gene Regulatory Networks
1
2012
7
0.020
Why?
Protein Precursors
1
2012
3
0.020
Why?
Alcoholism
1
2015
235
0.020
Why?
Double-Blind Method
1
2012
138
0.020
Why?
Multilingualism
1
2012
7
0.020
Why?
Chicago
1
2012
24
0.020
Why?
Amiodarone
1
2012
2
0.020
Why?
Postoperative Period
1
2012
15
0.020
Why?
Informed Consent
1
2012
18
0.020
Why?
Drug Approval
1
2012
11
0.020
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
14
0.020
Why?
Glucuronidase
1
2011
1
0.020
Why?
Fibroblast Growth Factor 2
1
2011
1
0.020
Why?
Receptors, Fibroblast Growth Factor
1
2011
1
0.020
Why?
Myocytes, Cardiac
1
2011
2
0.020
Why?
Wounds and Injuries
1
2012
40
0.020
Why?
Mice, Inbred C57BL
1
2011
16
0.020
Why?
Philippines
1
2011
25
0.020
Why?
Drug Utilization Review
2
2003
21
0.020
Why?
Decision Making
1
2013
164
0.020
Why?
Signal Transduction
1
2011
29
0.020
Why?
Nitric Oxide Donors
1
2011
1
0.020
Why?
Critical Care
1
2012
62
0.020
Why?
Critical Illness
1
2012
53
0.020
Why?
Ultrasonography, Doppler
1
2011
4
0.020
Why?
Delayed Diagnosis
1
2011
21
0.020
Why?
Weight Loss
1
2013
302
0.020
Why?
United States Department of Veterans Affairs
1
2011
113
0.020
Why?
Insurance Coverage
1
2011
102
0.020
Why?
Proviruses
1
1990
1
0.020
Why?
Internationality
1
2010
11
0.020
Why?
Virus Replication
1
1990
14
0.020
Why?
Health Planning Guidelines
1
2010
8
0.020
Why?
Parathyroid Hormone
1
2010
8
0.020
Why?
HIV-1
1
1990
72
0.020
Why?
Medication Therapy Management
1
2010
5
0.020
Why?
Self Report
1
2011
248
0.020
Why?
Prescriptions
1
2010
28
0.020
Why?
Pulsatile Flow
1
2009
1
0.020
Why?
Chemotherapy, Adjuvant
1
2010
79
0.020
Why?
Principal Component Analysis
1
2009
21
0.020
Why?
Statistics, Nonparametric
1
2010
45
0.020
Why?
Emigration and Immigration
1
2009
14
0.020
Why?
Etidronic Acid
1
2009
3
0.020
Why?
Tooth Extraction
1
2009
4
0.020
Why?
Alendronate
1
2009
15
0.020
Why?
Psychometrics
1
2010
114
0.020
Why?
Educational Status
1
2009
163
0.020
Why?
Emigrants and Immigrants
1
2009
26
0.020
Why?
Injections, Subcutaneous
1
2008
4
0.020
Why?
Injections, Intravenous
1
2008
10
0.020
Why?
5-Lipoxygenase-Activating Proteins
1
2008
2
0.020
Why?
Linkage Disequilibrium
1
2008
23
0.020
Why?
Promoter Regions, Genetic
1
2008
12
0.020
Why?
Public Health
1
2009
80
0.020
Why?
Alleles
1
2008
59
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2007
2
0.020
Why?
Diagnosis, Differential
2
2000
52
0.020
Why?
Disease Susceptibility
1
2007
36
0.020
Why?
Cell Line, Tumor
1
2007
10
0.020
Why?
Mutagenesis
1
2007
4
0.020
Why?
Manometry
1
2007
1
0.020
Why?
Protein Array Analysis
1
2007
3
0.020
Why?
Tissue Plasminogen Activator
1
2007
24
0.020
Why?
Sulfonylurea Compounds
1
2007
30
0.020
Why?
Thiazolidinediones
1
2007
41
0.020
Why?
Metformin
1
2007
49
0.020
Why?
Early Diagnosis
1
2007
33
0.020
Why?
Adrenal Cortex Hormones
1
2007
66
0.020
Why?
Leisure Activities
1
2006
29
0.010
Why?
Pacific Islands
1
2005
6
0.010
Why?
Phosphorus
1
2005
6
0.010
Why?
Drug Resistance
1
2005
19
0.010
Why?
Heparin
1
2004
9
0.010
Why?
Radiography
1
2004
34
0.010
Why?
Lung Neoplasms
1
2008
268
0.010
Why?
Wrist Injuries
1
2003
1
0.010
Why?
Spinal Fractures
1
2003
12
0.010
Why?
Women's Health
1
2004
178
0.010
Why?
Vitamin K 1
1
2001
1
0.010
Why?
Half-Life
1
2001
5
0.010
Why?
Economics, Pharmaceutical
1
2001
2
0.010
Why?
Sampling Studies
1
2001
38
0.010
Why?
Syndrome
1
2001
22
0.010
Why?
Drug Therapy
1
2001
16
0.010
Why?
Hospitals, Community
1
2001
23
0.010
Why?
Health Education
1
2001
79
0.010
Why?
Controlled Clinical Trials as Topic
1
2000
3
0.010
Why?
Troponin
1
2000
11
0.010
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
104
0.010
Why?
Meta-Analysis as Topic
1
2000
23
0.010
Why?
Patient Satisfaction
1
2001
186
0.010
Why?
Medicare Part A
1
1999
3
0.010
Why?
Medical Audit
1
1999
31
0.010
Why?
Hospitals, University
1
1999
14
0.010
Why?
Probability
1
1999
66
0.010
Why?
Hospitals, General
1
1995
3
0.010
Why?
Massachusetts
1
1995
58
0.010
Why?
Schools, Medical
1
1995
23
0.010
Why?
Globins
1
1990
1
0.010
Why?
Lymphocytes
1
1990
1
0.010
Why?
Oligonucleotide Probes
1
1990
3
0.010
Why?
Cloning, Molecular
1
1990
4
0.010
Why?
Kinetics
1
1990
12
0.010
Why?
Cells, Cultured
1
1990
12
0.010
Why?
Base Sequence
1
1990
14
0.010
Why?
Molecular Sequence Data
1
1990
16
0.010
Why?
Lymphocyte Activation
1
1990
6
0.010
Why?
DNA, Viral
1
1990
18
0.010
Why?
Leukocytes
1
1990
9
0.010
Why?
Polymerase Chain Reaction
1
1990
48
0.010
Why?
Concepts (944)
Explore
_
Co-Authors (54)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2026 Kaiser Permanente

Your Privacy Choices